<p>Health In Tech NASDAQ: HIT 报告了 2026 年第一季度的收入增长和更大的亏损，管理层表示公司正在有意增加对销售分销、承运人关系和技术开发的投资，以追求更大份额的自筹资金健康保险市场。</p>
<p>获取 <strong>Health In Tech</strong> 警报：</p>
<p>在公司的财报电话会议上，首席执行官 Tim Johnson 表示，Health In Tech 正在一个他所描述的 “庞大且不透明” 的自筹资金止损保险市场中运营，在这个市场中，大型企业的采用率远高于中小型企业。根据行业估计，Johnson 表示截至 2025 年，约 80% 的大型企业已采用自筹资金健康计划，而中小型企业的比例约为 27%。</p>
<p>Johnson 表示，公司基于人工智能的平台旨在减少实施自筹资金计划的复杂性。他表示，Health In Tech 目前与约 900 个分销合作伙伴合作，主要是保险经纪人，而根据行业估计，保险经纪人的总数超过 100 万。</p>
<p>“我们在经纪人池中的渗透率仍远低于千分之一，这突显了前方巨大的增长潜力，” Johnson 说。</p>
<h2>收入增长，公司重申全年展望</h2>
<p>首席财务官 Julia Qian 表示，2026 年第一季度的总收入为 880 万美元，比去年同期增长约 9%。调整后的 EBITDA 为负 130 万美元，而去年同期为正 120 万美元。净亏损为 160 万美元，而去年同期净收入为 50 万美元。</p>
<p>Qian 表示，相较于之前的时期，收入增长放缓反映了当前业务扩展阶段，而不是需求或平台可扩展性的变化。她表示，收入增长与分销网络的扩展、经纪人活动和管道机会的转化相关，公司在 2026 年将对此进行投资。</p>
<p>Health In Tech 重申其 2026 年全年收入指引为 4500 万美元至 5000 万美元，Johnson 表示这将代表约 35% 至 50% 的同比增长。</p>
<p>公司在季度末拥有 1030 万美元的现金及现金等价物，反映了在 3 月份完成的公开股权私募投资（PIPE）的收益。Johnson 表示，此次融资带来了约 700 万美元的毛收益，并不是出于对营运资金的迫切需求。相反，他表示公司看到了扩大股东基础和为增长计划增加资本的机会。</p>
<h2>运营费用因计划投资而增加</h2>
<p>Qian 表示，季度总运营费用为 670 万美元，约占收入的 76%，而去年同期为 490 万美元，约占收入的 41%。</p>
<ul>
<li>销售和营销费用为 230 万美元，约占收入的 26%，高于去年同期的 110 万美元，约占收入的 14%。</li>
<li>一般和行政费用为 350 万美元，约占收入的 39%，而去年同期为 320 万美元，约占收入的 41%。</li>
<li>研发费用为 90 万美元，约占收入的 10%，而去年同期为 50 万美元，约占收入的 7%。</li>
</ul>
<p>Qian 表示，公司在第一季度还资本化了约 60 万美元的软件开发费用。她表示，整体费用反映了向增长计划 “有目的的资本配置转变”，并预计在 2026 年将继续保持高水平的投资。</p>
<p>在问答环节中，Qian 表示与达沃斯会议相关的费用约为 20 万美元。她还表示，第一季度约 10 万美元的费用可能不会从运营费用的角度延续。</p>
<h2>新指标旨在显示平台活动和收入可见性</h2>
<p>Qian 引入了两个新的业务指标：合同收入和平台投放计划价值（PPPV）。</p>
<p>合同收入代表在未来期间预计确认的活跃保单上的合同承诺收入。Qian 表示，截至 3 月 31 日，2026 年剩余三个季度的合同收入总计约为 2290 万美元。包括第一季度报告的 880 万美元，她表示 Health In Tech 预计在 2026 财年将从现有合同中报告 3170 万美元的收入，未考虑每月调整。</p>
<p>PPPV 代表通过公司平台投放的自筹资金健康计划的总合同价值，包括保费、索赔基金和管理费用。Qian 表示，Health In Tech 在 2026 年第一季度投放了 8200 万美元的自筹资金止损计划。</p>
<p>公司将停止使用之前的已注册员工指标。Qian 表示，该指标未能充分反映覆盖类型和计划层级之间的差异，或员工变动（如雇佣、辞职和家庭状态变化）的影响。</p>
<h2>管理层专注于经纪人、承运人和技术</h2>
<p>Johnson 表示，Health In Tech 计划在多个领域部署资本：扩展销售分销网络、增加承运人合作伙伴、增强技术架构和人工智能开发，以及推进服务和产品开发。</p>
<p>首席增长官 Zain Hasan 表示，公司内部销售团队主要专注于引导和激活分销合作伙伴，而不是直接向雇主账户销售。他表示，Health In Tech 在 2025 年通过六人的内部销售团队创造了 3300 万美元的收入，现在计划选择性地扩展该团队。</p>
<p>在回应分析师提问时，Hasan 表示，公司打算招聘两到三名专注于外向销售的销售代表，以提高经纪人对平台的认知。</p>
<p>约翰逊表示，增加更多的承运商合作伙伴很重要，因为这为经纪人提供了同一雇主集团的更多承保视角，从而增加了续约时获得竞争性选择的可能性。他表示，这可能会改善平台的使用率、雇主的留存率和收入增长。</p>
<p>该公司还在投资平台改进。约翰逊表示，Health In Tech 与亚马逊网络服务的高级服务合作伙伴 Cyclom 合作，以扩展前端和后端功能。他表示，这项工作旨在改善平台能力、报告、工作流程集成和数据基础设施。</p>
<p>约翰逊还描述了公司 e-dibs 平台的更新，包括更新的界面、改进的工作流程设计、增强的人口统计洞察、扩展的大型团体报价功能、承保状态可见性、自动化的经验数据解析、基于人工智能的风险洞察以及平台内经纪人与承保人之间的消息传递。他表示，早期的经纪人反馈积极，特别是在消息传递和工作流程改进方面。</p>
<h2>三年费率稳定计划进展</h2>
<p>Health In Tech 正在开发一项三年费率稳定计划，旨在减少定价波动并为雇主集团提供更大的成本可预测性。约翰逊表示，公司预计将在 2026 年第二季度末至第三季度完成市场测试。</p>
<p>在问答环节中，约翰逊表示需求开始出现，公司已将该计划修改为不依赖特定承运商。他表示，Health In Tech 开始提供提案，并 “预计至少会有一项” 协议在第二季度达成，尽管他警告说，直到完成之前一切都不是最终的。</p>
<p>钱表示，公司对该计划的预测是保守的，并假设销售将在第四季度开始，指出较大的团体通常在年末购买这类计划。哈桑表示，该计划针对较大的雇主，通常涉及较长的销售周期，因为经纪人和雇主需要对结构感到舒适。</p>
<p>钱表示，三年计划的收入确认将从生效日期起按月进行，公司将提供未来 36 个月合同收入的额外可见性。约翰逊表示，该计划不需要预付押金。</p>
<p>约翰逊还表示，Health In Tech 预计将在第二季度开始初步的测试，推出一种数据驱动的解决方案，该方案整合心理数据和索赔数据，以为合作伙伴和雇主客户生成可操作的洞察。</p>
<h2>关于 Health In Tech NASDAQ: HIT</h2>
<p>Health in Tech, Inc 从事保险技术平台的提供，提供医疗行业流程的市场。其服务包括 Stone Mountain Risk、eDIYBS、HI Card、HI Performance Network 和附属产品。该公司由蒂姆·约翰逊于 2014 年创立，总部位于佛罗里达州斯图尔特。</p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在 Health In Tech 吗？</h2>
<p>在考虑投资 Health In Tech 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 Health In Tech 并不在名单上。</p>
<p>虽然 Health In Tech 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

<p>Health In Tech (NASDAQ:HIT) 报告了 2026 年第一季度收入增长 9%，达到 880 万美元，但净亏损扩大至 160 万美元。该公司正在增加对销售和技术的投资，以争取更大份额的自筹资金健康保险市场，该市场在大型企业中采用率更高。首席财务官 Julia Qian 指出，总运营费用上升至 670 万美元，反映出向增长战略的转变。Health In Tech 重申其全年收入指导为 4500 万美元至 5000 万美元，表明潜在的年增长率为 35% 至 50%</p>

<p>Health In Tech NASDAQ: HIT reported first-quarter 2026 revenue growth and a wider loss as management said the company is intentionally increasing investment in sales distribution, carrier relationships and technology development to pursue a larger share of the self-funded health insurance market.</p>
<div class="lb-trans"><p>Health In Tech NASDAQ: HIT 报告了 2026 年第一季度的收入增长和更大的亏损，管理层表示公司正在有意增加对销售分销、承运人关系和技术开发的投资，以追求更大份额的自筹资金健康保险市场。</p>
</div><p>Get <strong>Health In Tech</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Health In Tech</strong> 警报：</p>
</div><p>On the company’s earnings call, Chief Executive Officer Tim Johnson said Health In Tech is operating in what he described as a “massive, opaque” self-funded stop-loss insurance market, where adoption remains far higher among large businesses than among small and medium-sized employers. Citing industry estimates, Johnson said roughly 80% of large businesses had adopted self-funded health plans as of 2025, compared with about 27% of medium and small businesses.</p>
<div class="lb-trans"><p>在公司的财报电话会议上，首席执行官 Tim Johnson 表示，Health In Tech 正在一个他所描述的 “庞大且不透明” 的自筹资金止损保险市场中运营，在这个市场中，大型企业的采用率远高于中小型企业。根据行业估计，Johnson 表示截至 2025 年，约 80% 的大型企业已采用自筹资金健康计划，而中小型企业的比例约为 27%。</p>
</div><p>Johnson said the company’s AI-powered platform is designed to reduce the complexity of implementing self-funded plans. He said Health In Tech currently works with about 900 distribution partners, primarily insurance brokers, while the broader pool of insurance brokers exceeds 1 million, according to industry estimates.</p>
<div class="lb-trans"><p>Johnson 表示，公司基于人工智能的平台旨在减少实施自筹资金计划的复杂性。他表示，Health In Tech 目前与约 900 个分销合作伙伴合作，主要是保险经纪人，而根据行业估计，保险经纪人的总数超过 100 万。</p>
</div><p>“Our penetration of the broker pool remains well below one-tenth of 1%, which highlights the significant runway potential ahead,” Johnson said.</p>
<div class="lb-trans"><p>“我们在经纪人池中的渗透率仍远低于千分之一，这突显了前方巨大的增长潜力，” Johnson 说。</p>
</div><h2>Revenue rises as company reiterates full-year outlook</h2>
<div class="lb-trans"><h2>收入增长，公司重申全年展望</h2>
</div><p>Chief Financial Officer Julia Qian said total revenue for the first quarter of 2026 was $8.8 million, up approximately 9% from the prior-year period. Adjusted EBITDA was negative $1.3 million, compared with positive $1.2 million a year earlier. Net loss was $1.6 million, compared with net income of $0.5 million in the prior-year period.</p>
<div class="lb-trans"><p>首席财务官 Julia Qian 表示，2026 年第一季度的总收入为 880 万美元，比去年同期增长约 9%。调整后的 EBITDA 为负 130 万美元，而去年同期为正 120 万美元。净亏损为 160 万美元，而去年同期净收入为 50 万美元。</p>
</div><p>Qian said the slower revenue growth relative to prior periods reflected the current stage of scaling the business rather than a change in demand or platform scalability. She said revenue growth is tied to expansion of the distribution network, broker activity and conversion of pipeline opportunities, areas in which the company is investing during 2026.</p>
<div class="lb-trans"><p>Qian 表示，相较于之前的时期，收入增长放缓反映了当前业务扩展阶段，而不是需求或平台可扩展性的变化。她表示，收入增长与分销网络的扩展、经纪人活动和管道机会的转化相关，公司在 2026 年将对此进行投资。</p>
</div><p>Health In Tech reiterated its full-year 2026 revenue guidance of $45 million to $50 million, which Johnson said would represent approximately 35% to 50% year-over-year growth.</p>
<div class="lb-trans"><p>Health In Tech 重申其 2026 年全年收入指引为 4500 万美元至 5000 万美元，Johnson 表示这将代表约 35% 至 50% 的同比增长。</p>
</div><p>The company ended the quarter with $10.3 million in cash and cash equivalents, reflecting proceeds from a private investment in public equity, or PIPE, completed in March. Johnson said the financing brought in approximately $7 million in gross proceeds and was not driven by an immediate need for working capital. Instead, he said the company saw an opportunity to broaden its shareholder base and add capital for growth initiatives.</p>
<div class="lb-trans"><p>公司在季度末拥有 1030 万美元的现金及现金等价物，反映了在 3 月份完成的公开股权私募投资（PIPE）的收益。Johnson 表示，此次融资带来了约 700 万美元的毛收益，并不是出于对营运资金的迫切需求。相反，他表示公司看到了扩大股东基础和为增长计划增加资本的机会。</p>
</div><h2>Operating expenses increase with planned investment</h2>
<div class="lb-trans"><h2>运营费用因计划投资而增加</h2>
</div><p>Qian said total operating expenses were $6.7 million in the quarter, or approximately 76% of revenue, compared with $4.9 million, or 41% of revenue, in the prior-year period.</p>
<div class="lb-trans"><p>Qian 表示，季度总运营费用为 670 万美元，约占收入的 76%，而去年同期为 490 万美元，约占收入的 41%。</p>
</div><ul>
<li>Sales and marketing expenses were $2.3 million, or about 26% of revenue, up from $1.1 million, or 14% of revenue, in the prior-year period.</li>
<li>General and administrative expenses were $3.5 million, or approximately 39% of revenue, compared with $3.2 million, or 41% of revenue, a year earlier.</li>
<li>Research and development expenses were $0.9 million, or about 10% of revenue, compared with $0.5 million, or 7% of revenue, in the prior-year period.</li>
</ul>
<div class="lb-trans"><ul>
<li>销售和营销费用为 230 万美元，约占收入的 26%，高于去年同期的 110 万美元，约占收入的 14%。</li>
<li>一般和行政费用为 350 万美元，约占收入的 39%，而去年同期为 320 万美元，约占收入的 41%。</li>
<li>研发费用为 90 万美元，约占收入的 10%，而去年同期为 50 万美元，约占收入的 7%。</li>
</ul>
</div><p>Qian said the company also capitalized approximately $0.6 million of software development during the first quarter. She said overall expenses reflect a “purposeful shift in capital allocation” toward growth initiatives, and she expects elevated investment to continue throughout 2026.</p>
<div class="lb-trans"><p>Qian 表示，公司在第一季度还资本化了约 60 万美元的软件开发费用。她表示，整体费用反映了向增长计划 “有目的的资本配置转变”，并预计在 2026 年将继续保持高水平的投资。</p>
</div><p>During the question-and-answer session, Qian said costs tied to the Davos conference were approximately $200,000. She also said about $100,000 of first-quarter costs likely would not carry forward from an operating expense perspective.</p>
<div class="lb-trans"><p>在问答环节中，Qian 表示与达沃斯会议相关的费用约为 20 万美元。她还表示，第一季度约 10 万美元的费用可能不会从运营费用的角度延续。</p>
</div><h2>New metrics aim to show platform activity and revenue visibility</h2>
<div class="lb-trans"><h2>新指标旨在显示平台活动和收入可见性</h2>
</div><p>Qian introduced two new business metrics: contracted revenue and platform placed plan value, or PPPV.</p>
<div class="lb-trans"><p>Qian 引入了两个新的业务指标：合同收入和平台投放计划价值（PPPV）。</p>
</div><p>Contracted revenue represents contractually committed revenue on active policies that is expected to be recognized in future periods. Qian said that as of March 31, contracted revenue for the remaining three quarters of 2026 totaled approximately $22.9 million. Including the $8.8 million reported in the first quarter, she said Health In Tech estimated $31.7 million in revenue would be reported for fiscal 2026 from existing contracts, before monthly adjustments.</p>
<div class="lb-trans"><p>合同收入代表在未来期间预计确认的活跃保单上的合同承诺收入。Qian 表示，截至 3 月 31 日，2026 年剩余三个季度的合同收入总计约为 2290 万美元。包括第一季度报告的 880 万美元，她表示 Health In Tech 预计在 2026 财年将从现有合同中报告 3170 万美元的收入，未考虑每月调整。</p>
</div><p>PPPV represents the aggregate contractual value of self-funded health plans with stop-loss insurance placed through the company’s platform, including premium, claims fund and administrative fees. Qian said Health In Tech’s platform placed $82 million of self-funded stop-loss plans in the first quarter of 2026.</p>
<div class="lb-trans"><p>PPPV 代表通过公司平台投放的自筹资金健康计划的总合同价值，包括保费、索赔基金和管理费用。Qian 表示，Health In Tech 在 2026 年第一季度投放了 8200 万美元的自筹资金止损计划。</p>
</div><p>The company is discontinuing its prior enrolled employee metric. Qian said that metric did not fully capture differences among coverage types and plan tiers, or the impact of employee changes such as hires, resignations and family status changes.</p>
<div class="lb-trans"><p>公司将停止使用之前的已注册员工指标。Qian 表示，该指标未能充分反映覆盖类型和计划层级之间的差异，或员工变动（如雇佣、辞职和家庭状态变化）的影响。</p>
</div><h2>Management focuses on brokers, carriers and technology</h2>
<div class="lb-trans"><h2>管理层专注于经纪人、承运人和技术</h2>
</div><p>Johnson said Health In Tech plans to deploy capital across several areas: expanding its sales distribution network, adding carrier partners, enhancing technology architecture and AI development, and advancing services and product development.</p>
<div class="lb-trans"><p>Johnson 表示，Health In Tech 计划在多个领域部署资本：扩展销售分销网络、增加承运人合作伙伴、增强技术架构和人工智能开发，以及推进服务和产品开发。</p>
</div><p>Chief Growth Officer Zain Hasan said the company’s in-house sales team is primarily focused on onboarding and activating distribution partners rather than directly selling to employer accounts. He said Health In Tech generated $33 million in revenue in 2025 with a six-person in-house sales team, and now plans to selectively expand that team.</p>
<div class="lb-trans"><p>首席增长官 Zain Hasan 表示，公司内部销售团队主要专注于引导和激活分销合作伙伴，而不是直接向雇主账户销售。他表示，Health In Tech 在 2025 年通过六人的内部销售团队创造了 3300 万美元的收入，现在计划选择性地扩展该团队。</p>
</div><p>In response to an analyst question, Hasan said the company intends to hire two to three sales representatives focused on outbound efforts to increase broker awareness of the platform.</p>
<div class="lb-trans"><p>在回应分析师提问时，Hasan 表示，公司打算招聘两到三名专注于外向销售的销售代表，以提高经纪人对平台的认知。</p>
</div><p>Johnson said adding more carrier partners is important because it gives brokers more underwriting perspectives for the same employer group, increasing the likelihood of a competitive option at renewal. He said that could improve platform utilization, employer retention and revenue growth.</p>
<div class="lb-trans"><p>约翰逊表示，增加更多的承运商合作伙伴很重要，因为这为经纪人提供了同一雇主集团的更多承保视角，从而增加了续约时获得竞争性选择的可能性。他表示，这可能会改善平台的使用率、雇主的留存率和收入增长。</p>
</div><p>The company is also investing in platform improvements. Johnson said Health In Tech engaged Cyclom, an Amazon Web Services advanced tier service partner, to expand front-end and back-end functionality. He said the work is intended to improve platform capabilities, reporting, workflow integration and data infrastructure.</p>
<div class="lb-trans"><p>该公司还在投资平台改进。约翰逊表示，Health In Tech 与亚马逊网络服务的高级服务合作伙伴 Cyclom 合作，以扩展前端和后端功能。他表示，这项工作旨在改善平台能力、报告、工作流程集成和数据基础设施。</p>
</div><p>Johnson also described updates to the company’s e-dibs platform, including a refreshed interface, improved workflow design, enhanced census insights, expanded large group quoting functionality, underwriting status visibility, automated experience data parsing, AI-driven risk insights and broker-to-underwriter messaging inside the platform. He said early broker feedback has been positive, particularly around messaging and workflow improvements.</p>
<div class="lb-trans"><p>约翰逊还描述了公司 e-dibs 平台的更新，包括更新的界面、改进的工作流程设计、增强的人口统计洞察、扩展的大型团体报价功能、承保状态可见性、自动化的经验数据解析、基于人工智能的风险洞察以及平台内经纪人与承保人之间的消息传递。他表示，早期的经纪人反馈积极，特别是在消息传递和工作流程改进方面。</p>
</div><h2>Three-year rate stabilization program advances</h2>
<div class="lb-trans"><h2>三年费率稳定计划进展</h2>
</div><p>Health In Tech is developing a three-year rate stabilization program designed to reduce pricing volatility and provide greater cost predictability for employer groups. Johnson said the company expects to complete market testing late in the second quarter into the third quarter of 2026.</p>
<div class="lb-trans"><p>Health In Tech 正在开发一项三年费率稳定计划，旨在减少定价波动并为雇主集团提供更大的成本可预测性。约翰逊表示，公司预计将在 2026 年第二季度末至第三季度完成市场测试。</p>
</div><p>During the Q&amp;A session, Johnson said demand is beginning to emerge and that the company has modified the program to be carrier agnostic. He said Health In Tech is starting to provide proposals and is “anticipating at least one” agreement in the second quarter, though he cautioned that nothing is final until completed.</p>
<div class="lb-trans"><p>在问答环节中，约翰逊表示需求开始出现，公司已将该计划修改为不依赖特定承运商。他表示，Health In Tech 开始提供提案，并 “预计至少会有一项” 协议在第二季度达成，尽管他警告说，直到完成之前一切都不是最终的。</p>
</div><p>Qian said the company’s forecast is conservative and assumes sales from the program beginning in the fourth quarter, noting that larger groups often purchase these types of plans toward year-end. Hasan said the program targets larger employers and typically involves a longer sales cycle as brokers and employers become comfortable with the structure.</p>
<div class="lb-trans"><p>钱表示，公司对该计划的预测是保守的，并假设销售将在第四季度开始，指出较大的团体通常在年末购买这类计划。哈桑表示，该计划针对较大的雇主，通常涉及较长的销售周期，因为经纪人和雇主需要对结构感到舒适。</p>
</div><p>Qian said revenue recognition for a three-year program would remain monthly from the effective date, with the company providing additional visibility into future contracted revenue over the 36-month period. Johnson said the program would not require an upfront deposit.</p>
<div class="lb-trans"><p>钱表示，三年计划的收入确认将从生效日期起按月进行，公司将提供未来 36 个月合同收入的额外可见性。约翰逊表示，该计划不需要预付押金。</p>
</div><p>Johnson also said Health In Tech expects to begin initial beta testing in the second quarter of a data-driven solution that integrates psychological data and claims data to generate actionable insights for partners and employer clients.</p>
<div class="lb-trans"><p>约翰逊还表示，Health In Tech 预计将在第二季度开始初步的测试，推出一种数据驱动的解决方案，该方案整合心理数据和索赔数据，以为合作伙伴和雇主客户生成可操作的洞察。</p>
</div><h2>About Health In Tech NASDAQ: HIT</h2>
<div class="lb-trans"><h2>关于 Health In Tech NASDAQ: HIT</h2>
</div><p>Health in Tech, Inc engages in the provision of insurance technology platforms which offer a marketplace of processes in the healthcare industry. Its services include Stone Mountain Risk, eDIYBS, HI Card, HI Performance Network, and Ancillary Products. The company was founded by Tim Johnson in 2014 and is headquartered in Stuart, FL.</p>
<div class="lb-trans"><p>Health in Tech, Inc 从事保险技术平台的提供，提供医疗行业流程的市场。其服务包括 Stone Mountain Risk、eDIYBS、HI Card、HI Performance Network 和附属产品。该公司由蒂姆·约翰逊于 2014 年创立，总部位于佛罗里达州斯图尔特。</p>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Health In Tech Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Health In Tech 吗？</h2>
</div><p>Before you consider Health In Tech, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑投资 Health In Tech 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Health In Tech wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前立即购买……而 Health In Tech 并不在名单上。</p>
</div><p>While Health In Tech currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Health In Tech 目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Health In Tech 第一季度财报电话会议要点